Lung Cancer Surgery Market-Size, Share, Trends & Forecast 2030

Lung Cancer Surgery Market Data Product Overview

The Lung Cancer Surgery Market data product covers market sizing, segmentation, regional analysis, competitive benchmarking, and company profiling across the global market. The market is projected to reach USD 6.33 billion by 2030, reflecting a 4.9% CAGR from 2025–2030. Coverage spans surgical instruments, monitoring and visualizing systems, endosurgical equipment, robotic-assisted thoracic surgery systems, and other product types, alongside procedures, approaches, patient types, cancer stages, end users, and regions. The research combines primary interviews with industry experts and secondary research from proprietary databases and cited public industry sources, with historical figures and forecasts presented as reported in the syndicated study.

Use Cases

• Market entry sizing: Assess the projected 2030 market opportunity and evaluate demand across lobectomy, segmentectomy, wedge resection, and pneumonectomy.

• Competitive benchmarking: Compare 15 companies identified in the competitive landscape, including Medtronic, Siemens Healthineers AG, Accuray Incorporated, Olympus Corporation, and Intuitive Surgical Operations, Inc.

• Vendor evaluation: Assess opportunities around minimally invasive surgery, robotic-assisted thoracic surgery systems, endosurgical equipment, and monitoring and visualizing systems.

• Regional opportunity assessment: Compare North America, Europe, Asia-Pacific, and RoW to support geographic expansion and investment decisions.

Metadata

• Update Frequency: One-time syndicated research product; figures reflect the published study and its 2025–2030 forecast period.

• Data Source(s): Primary interviews + secondary research (proprietary databases, industry journals).

• Original Publisher of data: Next Move Strategy Consulting.

• Geographic coverage: North America, Europe, Asia-Pacific, and RoW, with regional analysis of the stated market segments.

• Is historical data "point-in-time": Historical figures are point-in-time as of publication; forecast years are projections.

• Data Set(s) Format(s): PDF / Excel.

• Raw or scraped data: No syndicated analyst research.

• Number of companies/brands covered: 15 Companies.

Key Data Points

• Rising Tobacco Consumption: Increasing tobacco and nicotine consumption contributes to higher lung cancer incidence and supports demand for lung cancer surgical procedures.

• Government Healthcare and R&D Initiatives: Increased government spending on healthcare research and development supports innovation in surgical methods and the adoption of advanced lung cancer treatment technologies.

• Rising Air Pollution: Increasing exposure to air pollution is identified as a market growth driver because pollutants can contribute to lung damage and increase the need for effective lung cancer treatment.

Pricing Information

Pricing is provided through the AWS Data Exchange offer. Current pricing and any applicable license-tier structure should be reviewed in the active AWS offer.

Regulatory and Compliance Information

This report is built from aggregated, publicly available, and licensed secondary sources plus expert interviews conducted on an aggregated basis. It contains no individually identifiable personal data.

Subscription Verification

AWS Data Exchange requires subscription verification on all public offers (subscribers confirm they're not in a restricted country or a covered party).